(Q51856923)

14 April 2018

editorial

0 references

title

H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic? (English)

1 reference

14 April 2018

0 references

1 reference

1 reference

1

1 reference

14 April 2018

Irina Isakova-Sivak

object named as

Irina Isakova-Sivak

series ordinal

2

0 references

author name string

Andrey Rekstin

series ordinal

3

1 reference

14 April 2018

publication date

28 November 2013

1 reference

14 April 2018

Expert Review of Vaccines

published in

1 reference

14 April 2018

volume

13

1 reference

14 April 2018

issue

1

1 reference

14 April 2018

page(s)

1-4

1 reference

14 April 2018

Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.864564

Biological features of novel avian influenza A (H7N9) virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.864564

Pathogenesis and transmission of avian influenza A (H7N9) virus in ferrets and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.864564

Influenza hemagglutinin and neuraminidase membrane glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.864564

A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.864564

A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.864564

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.864564

Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.864564

Cold-adapted pandemic 2009 H1N1 influenza virus live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.864564

Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.864564

Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.864564

Cross-protective immune responses elicited by live attenuated influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.864564

Pathogenesis, transmissibility, and ocular tropism of a highly pathogenic avian influenza A (H7N3) virus associated with human conjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.864564

Phylogenetic analysis of the hemagglutinin gene of low pathogenic avian influenza virus H7N7 strains in mallards in Northern Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.864564

H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2014.864564

10.1586/14760584.2014.864564

21 January 2018

Identifiers

DOI

1 reference

14 April 2018

1 reference

14 April 2018